New York, United States
Helaina, founded in 2019, is a pioneering biotech company headquartered in the United States that aims to redefine the role of food in health. By specializing in the production of human proteins for human nutrition, Helaina is leading the charge in the Biotechnology, Health Care, and Health and Wellness industries.
The company's innovative approach has garnered significant attention, culminating in a recent $45.00M Series B investment on 01 September 2024. This investment round was backed by a coalition of prominent investors including Barrel Ventures, Relish Works, Spark Capital, CF Private Equity, Siam Capital, Williams, Ingeborg Investments, Primary Venture Partners, and Avidity Partners.
Helaina's strong backing and its compelling mission position it as a key player in the evolving landscape of health-oriented biotechnology. For investors, Helaina presents a promising opportunity, blending cutting-edge science with pressing consumer health needs.
